Clinical Trial Update: A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold Versus Everolimus-eluting Metallic Stent in Long Coronary Lesions [NA]

View source ↗

Summary

This clinical trial update compares an everolimus-eluting bioresorbable vascular scaffold with an everolimus-eluting metallic stent for long coronary lesions in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Everolimus-eluting bioresorbable vascular scaffold (everolimus-eluting bioresorbable vascular scaffold)
• Everolimus-eluting metallic stent (everolimus-eluting stent)

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Disease | NA | Status: UNKNOWN